PCRSG Bio – Dr. Peter Grimm

Donate to the Prostate Cancer Treatment Research Foundation In Memory of Dr Peter Grimm In Memory

Peter Douglas Grimm, D.O.
July 17, 1952 – February 20, 2016

Founder and Director

Prostate Cancer Treatment
Research Foundation


Dr Peter Grimm, D.O.

Dr. Peter Grimm was a prostate cancer specialist, Director of the Prostate Cancer Center of Seattle and the founder of the Prostate Cancer Treatment Research Foundation. Dr. Grimm received his undergraduate education at Seattle University, medical education at Midwestern University (Chicago College of Osteopathic Medicine), Internship at Eastmoreland Hospital, Portland Oregon, and his graduate training in radiation oncology at UCLA. Dr. Grimm’s technical endeavors, such as the development of six U.S. patented devices, have led to continuous improvements in the equipment widely used in prostate cancer treatment.

Dr. Grimm led the Prostate Cancer Results Study Group ­­­­and established the Prostate Cancer Treatment Research Foundation in 2010 to publish the research data of the group.  He was devoted to patient education and worked tirelessly to give patients worldwide access to all the information needed to make informed decisions on their treatment. Dr Peter Grimm believed that patients had the opportunity to make a choice when it came to treatment of their prostate cancer. Dr Grimm founded the Prostate Cancer Treatment Research Foundation whose sole purpose is to provide information about the effectiveness of prostate cancer treatments allowing patients to make an informed decision. If you would like to help Peter’s vision live on, please make a donation to the Prostate Cancer Treatment Research Foundation in Memory of Dr Peter Grimm, Founder and Director, July 17, 1952 to February 20, 2016.


Donate to the Prostate Cancer Treatment Research Foundation in Memory of Dr Peter Grimm

If you would prefer to contact us directly, we suggest using email, phone or US mail. Contact information is listed in the footer section at the bottom of each page. Thank you for your interest and contribution to the work of the Prostate Cancer Results Study Group.